Morteza Jafarinia

43.1k total citations
52 papers, 969 citations indexed

About

Morteza Jafarinia is a scholar working on Molecular Biology, Oncology and Psychiatry and Mental health. According to data from OpenAlex, Morteza Jafarinia has authored 52 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Psychiatry and Mental health. Recurrent topics in Morteza Jafarinia's work include Extracellular vesicles in disease (7 papers), Mesenchymal stem cell research (7 papers) and MicroRNA in disease regulation (6 papers). Morteza Jafarinia is often cited by papers focused on Extracellular vesicles in disease (7 papers), Mesenchymal stem cell research (7 papers) and MicroRNA in disease regulation (6 papers). Morteza Jafarinia collaborates with scholars based in Iran, United States and Ireland. Morteza Jafarinia's co-authors include Mazdak Ganjalıkhani-Hakemi, Nahid Eskandari, Shahin Akhondzadeh, Fereshteh Alsahebfosoul, Hossein Salehi, Alireza Ghajar, Farshid Fathi, Abbas Tafakhori, Sina Vakili and Mina Tabrizi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Journal of Affective Disorders.

In The Last Decade

Morteza Jafarinia

48 papers receiving 956 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morteza Jafarinia Iran 15 276 156 128 110 108 52 969
Yumiko Nakano Japan 26 475 1.7× 148 0.9× 76 0.6× 130 1.2× 48 0.4× 114 1.7k
Carla Petrella Italy 25 441 1.6× 129 0.8× 52 0.4× 59 0.5× 41 0.4× 100 1.6k
Monika Paul-Samojedny Poland 21 419 1.5× 98 0.6× 302 2.4× 90 0.8× 113 1.0× 64 1.2k
Xiaojie Zhang China 24 648 2.3× 116 0.7× 163 1.3× 77 0.7× 166 1.5× 88 1.5k
Fiorenzo Mignini Italy 23 461 1.7× 132 0.8× 96 0.8× 114 1.0× 27 0.3× 80 1.5k
Hae Jeong Park South Korea 23 697 2.5× 74 0.5× 114 0.9× 86 0.8× 105 1.0× 94 1.7k
Yihuan Chen China 16 356 1.3× 70 0.4× 80 0.6× 46 0.4× 81 0.8× 44 784
Hua Hu China 25 588 2.1× 107 0.7× 53 0.4× 99 0.9× 131 1.2× 121 1.7k
Anne‐Sofie Johansson Sweden 18 305 1.1× 67 0.4× 122 1.0× 135 1.2× 46 0.4× 43 1.4k
Aric F. Logsdon United States 20 535 1.9× 82 0.5× 136 1.1× 59 0.5× 45 0.4× 33 1.8k

Countries citing papers authored by Morteza Jafarinia

Since Specialization
Citations

This map shows the geographic impact of Morteza Jafarinia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morteza Jafarinia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morteza Jafarinia more than expected).

Fields of papers citing papers by Morteza Jafarinia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morteza Jafarinia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morteza Jafarinia. The network helps show where Morteza Jafarinia may publish in the future.

Co-authorship network of co-authors of Morteza Jafarinia

This figure shows the co-authorship network connecting the top 25 collaborators of Morteza Jafarinia. A scholar is included among the top collaborators of Morteza Jafarinia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morteza Jafarinia. Morteza Jafarinia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oliaee, Razieh Tavakoli, et al.. (2025). MicroRNA dysregulation and target genes in common spinal tumors. Cancer Genetics. 292-293. 124–130.
2.
Jafarinia, Morteza, et al.. (2025). miRNAs from mesenchymal-stem-cell-derived extracellular vesicles: Emerging players in regenerative medicine and disease therapy. Molecular Therapy — Nucleic Acids. 36(4). 102715–102715.
3.
4.
Farrokhi, Majid Reza, et al.. (2024). Therapeutic prospects of microRNAs derived from mesenchymal stem cell extracellular vesicles in rheumatoid arthritis: a comprehensive overview. Molecular and Cellular Biochemistry. 480(3). 1275–1286. 3 indexed citations
5.
Samare‐Najaf, Mohammad, et al.. (2024). The Growth Inhibitory Effect of Resveratrol and Gallic Acid on Prostate Cancer Cell Lines through the Alteration of Oxidative Stress Balance: The Interplay between Nrf2, HO-1, and BACH1 Genes. Anti-Cancer Agents in Medicinal Chemistry. 24(16). 1220–1232. 1 indexed citations
6.
Jafarinia, Morteza, Majid Reza Farrokhi, Sina Vakili, et al.. (2023). Harnessing the therapeutic potential of mesenchymal stem/stromal cell-derived extracellular vesicles as a novel cell-free therapy for animal models of multiple sclerosis. Experimental Neurology. 373. 114674–114674. 5 indexed citations
7.
Iravanpour, Farideh, Majid Reza Farrokhi, Morteza Jafarinia, & Razieh Tavakoli Oliaee. (2023). The effect of SARS-CoV-2 on the development of Parkinson's disease: the role of α-synuclein. Human Cell. 37(1). 1–8. 5 indexed citations
8.
9.
Farrokhi, Majid Reza, Sina Vakili, Davoud Rostamzadeh, et al.. (2023). Effect of Disease-Modifying Therapies on COVID-19 Vaccination Efficacy in Multiple Sclerosis Patients: A Comprehensive Review. Viral Immunology. 36(6). 368–377. 3 indexed citations
10.
Chiari, C., Behzad Mansoori, Hossein Sadeghi, et al.. (2023). The mTOR Signaling Pathway Interacts with the ER Stress Response and the Unfolded Protein Response in Cancer. Cancer Research. 83(15). 2450–2460. 25 indexed citations
11.
12.
Jafarinia, Morteza, et al.. (2022). PI3K/Akt/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy. Immunologic Research. 70(3). 269–275. 49 indexed citations
13.
Jafarinia, Morteza, et al.. (2022). The Role of Immune Regulatory Molecules in COVID-19. Viral Immunology. 35(5). 359–364. 3 indexed citations
14.
Jafarinia, Morteza, Fereshteh Alsahebfosoul, Hossein Salehi, Nahid Eskandari, & Mazdak Ganjalıkhani-Hakemi. (2020). Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Novel Cell-Free Therapy. Immunological Investigations. 49(7). 758–780. 79 indexed citations
15.
Jafarinia, Morteza, Fereshteh Alsahebfosoul, Hossein Salehi, et al.. (2020). Therapeutic effects of extracellular vesicles from human adipose‐derived mesenchymal stem cells on chronic experimental autoimmune encephalomyelitis. Journal of Cellular Physiology. 235(11). 8779–8790. 66 indexed citations
16.
Jafarinia, Morteza, et al.. (2019). A Review of Medicinal Properties of some Asteraceae Family Plants on Immune System. 5(2). 1–7. 11 indexed citations
17.
Jafarinia, Morteza, et al.. (2019). Male microchimerism in peripheral blood from women with multiple sclerosis in Isfahan Province. International Journal of Immunogenetics. 47(2). 175–179. 9 indexed citations
18.
Jafarinia, Morteza, et al.. (2019). First case report of pulmonary and cutaneous nocardiosis caused by Nocardia mexicana in Iran. Access Microbiology. 1(4). e000016–e000016. 4 indexed citations
19.
Shahmansouri, Nazila, et al.. (2018). Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial. Journal of Affective Disorders. 235. 236–241. 58 indexed citations
20.
Jafarinia, Morteza, et al.. (2012). Non Cuffed Catheter Related Complications and Survival among Iranian ESRD Patients Treated in Hasheminejad Kidney Center; 2010-2011. 2(2). 1–1. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yumiko Nakano Breakdown of academic impact, for papers by Carla Petrella Breakdown of academic impact, for papers by Monika Paul-Samojedny Breakdown of academic impact, for papers by Xiaojie Zhang Breakdown of academic impact, for papers by Fiorenzo Mignini Breakdown of academic impact, for papers by Hae Jeong Park Breakdown of academic impact, for papers by Yihuan Chen Breakdown of academic impact, for papers by Hua Hu Breakdown of academic impact, for papers by Anne‐Sofie Johansson Breakdown of academic impact, for papers by Aric F. Logsdon
Rankless by CCL
2026